The ‘Pathogen Hunters’ track microbes around the world. But are their data real? | Science | AAAS
Opens in a new window
Opens an external website
Opens an external website in a new window
<!---->Close this consent banner<!---->
We and our 3 IAB TCF partners store and access information on your device for the following purposes: store and/or access information on a device, advertising and content measurement, audience research, and services development, personalised advertising, and personalised content.
Personal data may be processed to do the following: use precise geolocation data and identify devices based on information actively requested.
Our third party IAB TCF partners may store and access information on your device such as IP address and device characteristics. Our IAB TCF Partners may process this personal data on the basis of legitimate interest, or with your consent. You may change or withdraw your preferences for this website at any time by clicking on the cookie icon or link; however, as a consequence, you may not see relevant ads or personalized content.
You may change your settings at any time or accept the default settings.
You may close this banner to continue with only essential cookies.
<!----><!---->
science translational medicine
Quick Search in Journals
Enter Search Term
Quick Search in Journals
Enter Search Term
Quick Search in Journals
Enter Search Term
Quick Search in Journals
Enter Search Term
Quick Search in Journals
Enter Search Term
Quick Search in Journals
Enter Search Term
Searching:
Science Translational Medicine
Advanced Search
science.org
science translational medicine
Main content starts here
ScienceInsider
Scientific Community
Exclusive: The ‘Pathogen Hunters’ track microbes around the world. But are their data real?
Critics question baffling genetic data from prolific infectious diseases group
Sooty gulls perch on rocks on the island of Socotra in Yemen, one of 10 countries where Pathogen Hunters claims it collected guano for an avian influenza study.
Chuck David/VWPics via AP Images
Share:
A version of this story appeared in Science, Vol 394, Issue 6825.
Download PDF
Go ten seconds backward
Skip forwards
Go ten seconds forward
Progress
1.0x
Mute
Unmute
Volume is at 50%
00:00
1.0x
Audio is AI-generated.
In May 2025, a paper in
Nature Communications
made a startling claim about avian influenza viruses found in guano from Africa, the Middle East, Asia, and Oceania. Genetic sequences of some viruses were identical to those of strains found years earlier, in distant locales, claimed the authors, a group that calls itself
Pathogen Hunters
and is led by Dhammika Leshan Wannigama of Yamagata University in Japan.
The finding challenged scientists’ understanding of flu virus evolution, calling into question risk assessments and policies meant to protect livestock and humans. To skeptics, however, the claim was highly implausible, because flu viral RNA is always changing.
Last week,
airing the skeptics’ doubts. The study had “widespread sequencing errors” that could lead to “misleading conclusions,” 13 flu researchers wrote in a peer-reviewed commentary. An accompanying
rebuttal
from Pathogen Hunters said it had fixed the problems, but that didn’t satisfy the critics. “All our concerns still stand,” says Michelle Wille, a wildlife ecologist at the University of Melbourne who specializes in avian influenza and spearheaded the critique.
SCIENCE
ADVISER NEWSLETTER
The latest news, commentary, and research, free to your inbox daily
It’s not the only paper by Pathogen Hunters that has come under criticism. Over the past 4 years, the group has published dozens of eye-catching studies for which it claims to have collected more than 60,000 samples in 38 countries, including
war-torn nations
such as Yemen, Somalia, and Sudan. It has sampled wastewater from 11 countries to look for
SARS-CoV-2
; tested discarded
condoms
from brothels and public restrooms for the mpox virus; and found a tapeworm that sickens humans in feces from
wild bears
. Critics question how the group could have collected so many samples in such a short period, and they have found anomalies in the genomic data of at least five papers.
“It all just seemed weird that one group could possibly be doing this,” says Paul Sharp, a semiretired evolutionary biologist at the University of Edinburgh. Like some other critics, he suspects misconduct. “When you dig into more detail about the data they’ve produced, it’s bogus.” Sharp’s analyses led
The Journal of Infectious Diseases
(
JID
) to retract one paper and add an “expression of concern” to another. Wannigama and co-authors have published substantive corrections to the
bird flu study
and one on
COVID-19 monitoring
.
The many complaints about Wannigama’s work led Yamagata University in May to launch an
investigation
into “research integrity matters.” In response to questions from
Science
, Wannigama said he wanted to wait for its outcomes “out of respect for that ongoing administrative process, and in compliance with strict institutional data privacy policies.” A university administrator says the investigation “does not include any of Dr. Wannigama’s collaborators.” The school hopes to reach a final conclusion next month.
Originally from Sri Lanka, Wannigama, 40, obtained a
Ph.D.
at Chulalongkorn University in Thailand in 2019. He has listed an affiliation with the University of Western Australia on several papers, but the school told
Science
he was “an international student who enrolled in a postgraduate course … in 2018 but did not complete it.”
Pathogen Hunters says it’s on “a mission to stop the world’s deadliest threats.” Its website features Wannigama and 15 main investigators, most of them based in Japan and Thailand, with 24 collaborators in 20 other countries. (After this story appeared, Pathogen Hunters took down its website and posted a “Site Under Maintenance” notice, but
Science
saved the site on the
Wayback Machine
on 10 November.) Its primary funders include a cryptocurrency philanthropist and two personal “memorial” funds. Since launching Pathogen Hunters in 2022, Wannigama has published more than 70 papers.
The first warning of trouble came in 2024, after Pathogen Hunters published results from a large clinical trial in
eClinicalMedicine
showing that four cheap drugs used for other diseases also worked for COVID-19. On
PubPeer
, a forum for commenting on published studies, Mathieu Molimard, a pharmacologist from the University of Bordeaux, wrote that the treatments lacked “a plausible pharmacological basis,” data were missing, and the findings contradicted those from other “well-conducted clinical trials,” which together “completely undermine” the paper.
The
Nature Communications
paper caused more consternation. Pathogen Hunters reported that H5N1 viruses from 2021 and ’22 in Papua New Guinea, Indonesia, and Sri Lanka had sequences that exactly matched viruses found as many as 14 years earlier. More startling still, an H7 variant that surfaced in Australian poultry in 2020 but was eliminated by culling nearly half a million birds—and was never found in wild birds—showed up in those three countries and in the Maldives and Mozambique, implying it threatened poultry there. An H5 strain in Yemen and Somalia was highly similar to one only found in U.S. dairy herds. “It doesn’t make any sense,” Wille says.
“At first we gave them the benefit of the doubt, thinking these were just nonflu researchers who got in a little over their heads,” says a co-author on the critique who did not have permission from their employer to speak publicly. “But they were very squirrely about it with lots of excuses and very cryptic communications.” The critics also noted the study didn’t mention ethics approvals or permits to collect, export, and import avian-derived samples.
In its published reply, Wannigama’s team noted it sampled rarely surveyed locales and cautioned “against assuming that certain transmission patterns are impossible.” The researchers maintained their conclusions were based on the correct sequences, but said they accidentally submitted erroneous ones to a database called GISIAD, and had uploaded corrected sequences. The work “received ethical exemption approval from our institute in Japan,” they wrote, and the team “carefully confirmed with the relevant local authorities that no special permits were required for the type of environmental fecal waste sampling undertaken in this study.”
Since launching Pathogen Hunters in 2022, Dhammika Leshan Wannigama has published more than 70 papers.
Pathogenhunters.com
The corrected sequences only raise new questions, says Richard Neher, a computational biologist at the University of Basel who had criticized the original paper on
PubPeer
. “A couple of sequences were removed that were the most implausible, and there are little mutations in these data now that make these sequences unique,” Neher says. But in several cases only a single nucleotide was changed, and sometimes the changes don’t conform with expected mutation patterns. “This is very, very odd,” Neher says. “I don’t think these are genuine samples.”
Erik Karlsson, head virologist at the Pasteur Institute of Cambodia and co-author of the critique in
Nature Communications
, doesn’t buy the contention that the team had proper permits. “Most of the countries on their list have a law or ordinance about sharing biological materials,” he says.
Wille says
Nature Communications
should retract the paper and is baffled that it took 15 months to publish the criticism. “I just don’t understand what more they need,” she says. “This is a massive failure on the part of
Nature Communications
.” Ripudaman Bains, an editor at the journal, told
Science
the process included “engaging independent expert review of the [critique], the Reply, and the updated sequence data” and was completed as “swiftly and efficiently as possible.” The journal is “satisfied that the paper complies with our editorial policies including ethics policies,” Bains wrote.
More odd data
arrived in a March
, a malaria parasite that infects monkeys in Asia and spills over to humans. The team said it had tested 4752 macaque fecal samples collected in nine countries and found the parasite in 8.2% of them. Previous studies mostly relied on trapping wild monkeys and bleeding them to assess
P. knowlesi
prevalence, but the researchers said fecal sampling was a “scalable, ethical, and field-adaptable” alternative.
The finding excited Richard Culleton, a parasitologist at Ehime University who had attempted wild monkey fecal sampling for
P. knowlesi
but found it produced too many false-negative results. “Reading your paper has given us new hope!” he emailed Wannigama, asking how the team had collected samples, processed them, and obtained proper permissions.
Then he learned the team had not tested monkey blood to confirm the fecal findings; its philanthropic funders, Wannigama said, were “not comfortable” with invasive animal studies. That meant the assertion that monkey feces could be used to track the parasite was “wrong, and may confuse those of us working in the field,” he wrote to Wannigama.
Sharp, who collaborates with Culleton, found another warning sign when he examined the study’s
P. knowlesi
sequences in a public database called GenBank. The 387 entries only contained 33 unique sequences—and each one was already in GenBank before the Wannigama team’s upload. As he dug deeper, Sharp found more problems. “It’s not errors,” he says. “It’s fraud.” He notified
JID
, which retracted the paper in July, noting the authors “confirmed that they were unable to fully retrieve and verify the original raw sequencing files and associated metadata.”
Sharp found similar problems in a
JID
paper by the group on
Streptococcus pyogenes
and toxic shock, leading the journal to issue an “
expression of concern
” while it investigates that complaint. And Neher compiled detailed critiques of papers by Pathogen Hunters on mpox and two bacteria,
, which he shared with
Science
. “Whichever paper you look at, there seem to be issues,” he says.
The doubts extend
beyond research data
. Wannigama has signed emails to Culleton and Neher with “MD” after his name, but he didn’t mention the degree on a 2019 CV.
Science
found he was not listed in medical registries in Japan, Thailand, India, or Sri Lanka. Several of his papers credit local “LGBTQIA+ communities” with help collecting samples, but no individuals or specific groups are named, and it’s unclear why they would help collect bird guano or monkey feces for diseases that have no particular link to those lesbian, gay, bisexual, or transgender communities. “It’s a red flag when it keeps coming up in papers where it doesn’t belong,” says Joel Wertheim, an evolutionary biologist at the University of California San Diego.
The criticisms of Wannigama’s work also raise questions about the role of his dozens of co-authors.
Science
emailed 15 co-authors who appear on some or all of the six studies that have come under criticism. Ten did not respond. The other five said they were embarrassed by their involvement but contributed relatively little to the papers. Jonas Bonnedahl, an infectious disease clinician in Sweden who specializes in antimicrobial resistance and bird migration, said he was surprised Wannigama offered to make him a co-author on the
Nature Communications
paper. “I had two digital meetings with him about bird movement, and my input in the paper is not so much,” he says. Bonnedahl says he thought he was helping an early-career researcher but now feels “almost abused.”
A co-author on the retracted
P. knowlesi
paper, infectious disease clinician Ng Sin Hui at the University of Malaya Medical Centre, says he only commented on the manuscript and knew nothing about sample collection, ethical approval, or permits. “I should have sought more detailed clarification regarding certain methodological and regulatory aspects of the work,” Ng says. He says he met Wannigama just once, at a conference, and like other co-authors, contends Wannigama included him to bolster his credibility.
One co-author who asked not to be identified blames himself for not noticing that the supplement of a paper about SARS-CoV-2 in wastewater had five identical figures. That paper has been corrected, but Wannigama’s attitude about the problem bothered him. “Editors told me they don’t much care and we can correct the graph,” Wannigama wrote his co-author. “I am okay with people showing our mistakes.”
Unreliable data have real-world consequences, the critics stress. An mpox paper by Pathogen Hunters contained “shocking” claims and upended previous findings about viral evolution and spread, Wertheim says. Asserting that a dangerous bird flu variant circulates in a country “has really, really big ramifications,” Wille adds. And erroneous sequences in databases can lead to inaccurate family trees, confusing drug and vaccine developers. “We’re trying to solve public health problems,” Culleton says, “and this is just making our jobs more difficult.”
Correction, 11 November, 2:35 p.m.:
A previous version of this story said the birds in the photo at the top were shearwaters, as indicated in a caption provided by AP Images. They are actually sooty gulls.
doi: 10.1126/science.zxasfav
Relevant tags:
Jon Cohen, senior correspondent with
Science
, earned his B.A. in science writing from the University of California San Diego. He can be reached on Signal at
bval31.65 and on Bluesky at @cohenjon.bsky.social.
View more
10 Nov 2026
Can researchers bring order to the confusing world of AI ‘benchmarks’?
By
Ananya
9 Nov 2026
To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA
By
Phie Jacobs
9 Nov 2026
Researchers sue to block NSF from demolishing social science directorate
Got a tip for Science's news department?
Connect
Get
Science
’s award-winning newsletter with the latest news, commentary, and research, free to your inbox daily.
10 Nov 2026
By
Ananya
Can researchers bring order to the confusing world of AI ‘benchmarks’?
9 Nov 2026
By
Phie Jacobs
To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA
9 Nov 2026
By
Daniel Garisto
Researchers sue to block NSF from demolishing social science directorate
9 Nov 2026
By
Jeffrey Brainard
AI beats scientists at finding errors in clinical research papers
9 Oct 2026
By
Julia Vaz
Trump administration proposes $100,000 fee for work authorization for international students
6 Oct 2026
By
Taylor Mitchell Brown
Exclusive: Archaeology megafirm abruptly shuts down
4 Sep 2026
By
John Travis
Gene-edited pig kidney transplant sets record—and offers bridge to human organs
18 Aug 2026
By
Phie Jacobs
FDA pick is Heidi Overton
17 Mar 2023
By
Jocelyn Kaiser
Growing number of high-security pathogen labs around world raises concerns
News of the Week
May 2014
Around the World
News of the Week
November 2013
Around the World
News of the Week
December 2013
21 Oct 2026
Battle for the gut: From microbial competition to therapeutic communities
×
$50
$75
$100
Other
$
Please enter a valid amount
Single
Monthly
Email:
Please enter a valid email
Country:
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
British Indian Ocean Territory
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Cote D'Ivoire
Falkland Islands (Malvinas)
French Southern Territories
Heard Island and Mcdonald Islands
Holy See (Vatican City State)
Iran, Islamic Republic of
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Macedonia, The Former Yugoslav Republic of
Moldova, Republic of
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Sint Maarten (Dutch part)
South Georgia and the South Sandwich Islands
Svalbard and Jan Mayen
Tanzania, United Republic of
Turks and Caicos Islands
Venezuela, Bolivarian Republic of
Vietnam
Virgin Islands, British
also wish to receive emails from AAAS/Science and Science advertisers,
including information on products, services and special offers which may
include but are not limited to news, careers information & upcoming
events.
Support nonprofit science journalism
Amid the unprecedented upheaval in U.S. science, hard-hitting, trustworthy reporting has never been more important. As part of the AAAS mission,
Science
has built a global award-winning network of reporters and editors that independently cover the most important developments in research and policy.
Your tax-deductible contribution plays a critical role in sustaining this effort.
If, at any time, you would like to stop or make changes to your monthly gift, please contact the Philanthropy Office at
philanthropy@aaas.org
or 202-326-6636.
Charitable Disclosures
Loading...
×
Support nonprofit science journalism
Help News from
Science
publish trustworthy, high-impact stories about research and the people who shape it.
Please make a tax‑deductible gift today.
Thanks for sharing!